# Ultrasonic Neuromodulation for Treatment of Cognitive Impairment

> **NCT06135051** · PHASE1,PHASE2 · TERMINATED · sponsor: **University of Utah** · enrollment: 1 (actual)

## Conditions studied

- Alzheimer Disease
- Dementia
- Cognitive Impairment

## Interventions

- **DEVICE:** Diadem prototype

## Key facts

- **NCT ID:** NCT06135051
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-08-18
- **Primary completion:** 2024-08-21
- **Final completion:** 2024-08-21
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** IRB administrative closure
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06135051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06135051, "Ultrasonic Neuromodulation for Treatment of Cognitive Impairment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06135051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*